Treatment Outcomes for Adults and Adolescents in Mental Health Residential and Day Treatment
Skyland Trail is a trailblazer in the area of outcomes research, which is an integral part of our evidence-based treatment model. Our robust outcomes and research program employs evaluative instruments considered to be the gold standards in the mental health field to measure the effectiveness of our treatment programs.
Most patients have reduced symptoms as a result of treatment, and our outcomes data indicate that many patients make even more progress. They experience a clinically meaningful change – one that science has shown impacts how a patient feels and functions.
For many patients, this also means achieving remission. Based on cutoffs established in the psychiatric literature, remission means that the level of symptoms present no longer meets criteria for the diagnosis.
2024 Adult Patient Outcomes
Patients who completed assessment at discharge in 2024
Adult Patients with Depression-Related Disorders
Approximately 84% of adult patients admitting in 2024 reported major depression, bipolar disorder, or a related mood disorder as a primary diagnosis.
% Reduction in Depression Symptoms
39%
On average, patients experienced a 39% reduction in depression symptoms
Includes patients with primary mood disorders as well as patients with primary psychosis-related and anxiety-related disorders.
% Patients Who Improved
70%
Approximately 70% of patients experienced mild or minimal depression symptoms at discharge
% Remission at Discharge
32%
Approximately 32% of patients in CBT or DBT treatment experienced depression remission at discharge
% Remission with TMS
59%
Approximately 59% of patients receiving transcranial magnetic stimulation experienced remission in depression symptoms
Adult Patients with Anxiety Disorders
Approximately 56% of adult patients admitting in 2024 reported an anxiety disorder as a primary or co-occurring diagnosis.
% Reduction in Anxiety Symptoms
35%
On average, adult patients experienced a 35% reduction in anxiety symptoms
% Patients Who Improved
71%
Approximately 71% of patients experienced mild or minimal anxiety symptoms at discharge
Adult Patients with Psychosis-Related Disorders
Approximately 14% of adult patients admitting in 2024 reported schizophrenia or a psychosis-related disorder as a primary diagnosis.
% Reduction in Symptoms
55%
On average, patients receiving treatment for psychosis and cognition experienced a 55% reduction in risk of psychosis symptoms
2024 Adolescent Patient Outcomes
PATIENTS WHO COMPLETED ASSESSMENTS AT DISCHARGE IN 2024
Adolescent Patients with Depression-Related Disorders
Approximately 91% of adolescent patients admitting in 2024 reported major depression, bipolar disorder, or a related mood disorder as a primary diagnosis.
% Reduction in Symptoms
64%
On average, patients experienced a 64% reduction in depression symptoms
% Patients Who Improved
75%
Approximately 75% of patients experienced mild or minimal depression symptoms at discharge
Adolescent Patients with Anxiety Disorders
Approximately 77% of adolescent patients admitting in 2024 reported an anxiety disorder as a primary or co-occurring diagnosis.
% Reduction in Symptoms
25%
On average, patients experienced a 25% reduction in anxiety symptoms
% Patients Who Improved
58%
Approximately 58% of adolescent patients experienced average or low anxiety symptoms at discharge
Adolescent Patients with Trauma-Related Disorders
Approximately 27% of adolescent patients admitting in 2024 reported PTSD or a trauma-related disorder as a primary or co-occurring diagnosis.
% Patients Who Improved
88%
More than 88% of patients who completed Prolonged Exposure (PE) therapy saw a clinically significant reduction in PTSD symptoms
